TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 135 filers reported holding TG THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is 0.37 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $216,000 | -14.3% | 6,500 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $252,000 | -19.5% | 6,500 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $313,000 | -7.4% | 6,500 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $338,000 | -4.0% | 6,500 | -75.7% | 0.00% | -50.0% |
| Q2 2018 | $352,000 | -25.9% | 26,800 | -19.9% | 0.00% | 0.0% |
| Q1 2018 | $475,000 | +90.0% | 33,450 | +9.9% | 0.00% | +100.0% |
| Q4 2017 | $250,000 | – | 30,450 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Avoro Capital Advisors LLC | 5,229,619 | $74,261,000 | 3.55% |
| RA Capital Management | 2,472,344 | $35,107,000 | 2.69% |
| SENZAR ASSET MANAGEMENT, LLC | 475,918 | $6,758,000 | 2.13% |
| BRIDGER MANAGEMENT, LLC | 2,373,920 | $33,710,000 | 2.04% |
| Opaleye Management Inc. | 274,200 | $3,893,000 | 1.11% |
| Virtus ETF Advisers LLC | 89,920 | $1,277,000 | 1.11% |
| Eversept Partners, LP | 150,000 | $2,130,000 | 0.99% |
| Ghost Tree Capital, LLC | 300,000 | $4,260,000 | 0.86% |
| PURA VIDA INVESTMENTS, LLC | 50,000 | $710,000 | 0.42% |
| HIGHLAND CAPITAL MANAGEMENT LP | 464,391 | $6,595,000 | 0.34% |